News – Page 1024 – Endpoints News

Novartis oncology vet Stefan Scherer joins biotech migration to head clinical work, CAR-T partnership at Cellectis

7 years ago

Bristol-Myers, Scripps research team touts a new way to control 3D architecture of genetic drugs

7 years ago

Clovis writes a $20 million check payable to the SEC, hoping to rid itself of the lingering roci probe

7 years ago

Celtaxsys spins 'clinically meaningful' data on another failed PhII cystic fibrosis study

7 years ago

With high expectations on Provenge, Dendreon is 'sold' (again) in $832M deal

7 years ago

Teva falls on disappointing sales forecast; Akcea and PTC take two drugs to Latin America

7 years ago

Stock scandals: Biotech incubator Fortress purchased brokerage firm to tout its own startups — Reuters

7 years ago

As a new study spotlights a growing role for LRRK2 in Parkinson’s, Denali clears an early trial hurdle

7 years ago

Epizyme discards a failed program for tazemetostat as execs work to get an FDA hold lifted -- shares crater

7 years ago

BeiGene bags a staggering $903M IPO on the HKEX — and still manages to spark some nervous fretting

7 years ago

Can two old drugs — including an Eli Lilly flop — make one good treatment for Alzheimer’s? Karuna has $42M to ...

7 years ago

Genentech I/O chief Dan Chen heads to an upstart biotech looking to create a landmark advance on antibodies

7 years ago

EMA: More staff than anticipated quit ahead of Brexit relocation

7 years ago

Novartis dispatches two more cancer drug castoffs to a partner in China

7 years ago

Moderna's Ted Ashburn jumps to the helm at Oncorus; Arrowhead pockets $10M as Amgen doses first patient with its ...

7 years ago

The bar lowers yet again for PRV prices, with Kyowa/Ultragenyx selling at $80.6M

7 years ago

As NDA talks loom, FDA hands Daiichi Sankyo a ‘breakthrough’ on its $410M AML drug quizartinib

7 years ago

Game change: Pfizer doubles down on its late-stage pipeline as CEO Read disavows a long reliance on M&A deals

7 years ago

Ascletis breaks into HKEX, briefly rising on hotly anticipated public debut of first biotech

7 years ago

ReViral gets a $55M booster shot of cash as it expands its development work on an RSV treatment

7 years ago

Hammered by a series of setbacks, NewLink axes staff (again) and circles its wagons around troubled IDO program

7 years ago

FDA hustles through a quick OK for Shionogi's new thrombocytopenia drug

7 years ago

The Google of CRISPR tech? Tech legends Tim Cook and Jeff Huber back Mammoth Biosciences

7 years ago

Pfizer dumps 3 projects in Q2 pipeline pruning; Teva seals 12-year lease on new NJ headquarters

7 years ago

First page Previous page 1021 1022 102310241025 1026 1027 Next page Last page